![Michael Rudnicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Michael Rudnicki is the founder of Fate Therapeutics, Inc. (founded in 2007).
Dr. Rudnicki is the founder of Satellos Bioscience, Inc. (founded in 2018) and holds the title of Chief Discovery Officer.
Dr. Rudnicki is also the founder of Verio Therapeutics, Inc. Dr. Rudnicki is the Director-Sprott Centre for Stem Cell Research at Ottawa Hospital Research Institute.
Dr. Rudnicki is the Scientific Director at Stem Cell Network.
Dr. Rudnicki is a Professor at the University of Ottawa.
Dr. Rudnicki was the Director at The Ontario Institute For Regenerative Medicine.
Dr. Rudnicki earned an undergraduate degree and a doctorate from the University of Ottawa.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC 1,24 % | 02/04/2026 | 258.159 ( 1,24 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Fundador | 01/01/2018 |
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ottawa Hospital Research Institute
 Ottawa Hospital Research Institute Hospital/Nursing ManagementHealth Services Operates research hospitals | Corporate Officer/Principal | - |
Stem Cell Network
 Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Verio Therapeutics, Inc.
 Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells | Fundador | - |
The Ontario Institute For Regenerative Medicine
 The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Operates as stem cell and regenerative medicine research company | Director/Miembro de la Junta | - |
Satellos Bioscience, Inc. /Old/
 Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Fundador | - |
| FATE THERAPEUTICS, INC. | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
University of Ottawa
University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute Hospital/Nursing ManagementHealth Services Operates research hospitals | Health Services |
Verio Therapeutics, Inc.
Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells | Health Technology |
The Ontario Institute For Regenerative Medicine
The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Operates as stem cell and regenerative medicine research company | Commercial Services |
Satellos Bioscience, Inc. /Old/
Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Health Technology |
Stem Cell Network
Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services | Commercial Services |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
